SCHEDULE OF WARRANTS ISSUED (Details) |
3 Months Ended |
|---|---|
|
Mar. 31, 2026
$ / shares
shares
| |
| Equity [Abstract] | |
| Number of Warrants Outstanding, beginning | 914,640 |
| Weighted Average Exercise Price Outstanding, beginning | $ / shares | $ 0.10 |
| Number of Warrants Granted | |
| Number of Warrants Canceled/Expired | (468,795) |
| Weighted Average Exercise Price, Canceled/Expired | $ / shares | $ 0.10 |
| Number of Warrants Exercised | |
| Number of Warrants Outstanding, ending | 445,845 |
| Weighted Average Exercise Price Outstanding, ending | $ / shares | $ 0.10 |
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non-option equity instruments outstanding weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non-option equity instruments outstanding weighted average exercise price canceled. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|